Taiwan’s first case on treatment of a cerebral palsy boy with his own cord blood unit
17 Feb 2020
Text. Photo / Rebirth Biotech-Marketing
After birth, Mrs. Wang’s son appeared to be no different from normal babies; however, at 5-6 months of age, the baby could not turn his body over like a normal baby, who was then diagnosed by physician to have severe cerebral palsy.
In the November of 2006, Mrs. Wang inquired with Sino Cell about the possibility of treating cerebral palsy with stem cells. With Sino Cell’s assistance, Mrs. Wang learned that Duke University in the United Sates has already successfully completed similar stem cells transplantation. Owing to the excellent preservation and quality assurance of Sino Cell, the thawed stem cells retained excellent viability of the CD34+ cells, and with the recommendation of the medical team, Mrs. Wang’s baby son completed the cord blood transplantation.
Profile: Sino Cell’s Wang case
National Taiwan University Hospital (NTUH) and Chang Gung Memorial Hospital (CGMH) cooperated to complete Taiwan’s first case of using autologous cord blood unit (CBU) infusion to treat a patient with cerebral palsy.
Diagnosis: severe cerebral palsy
Date of the CBU therapy: 2007/2
Witness the miracle – Little Wang’s improved motor function
Diagnosed with severe cerebral palsy at 5-6 months of age
Beginning of 2007, the treatment with cord blood unit in commenced after physical evaluation made by physicians
Can turn over by himself in less than 2 months
May of 2007, learning to sit down and stand up without help
Spring of 2009, happy first day ofKindergarten
2010, celebrating Mother’s Day with the whole Wang’s famil